Brain–Machine
Wired for Healing: The Future of Brain–Machine Interfaces
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-03May 07, 2025
Real-World Analysis
XARELTO® Significantly Reduced Ischemic Stroke in Real-World Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulants
Janssen Pharmaceutical Companies
PR-M03-19-NI-044Mar 15, 2019
Real-World Study
New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli
Janssen Pharmaceutical Companies
PR-M05-18-NI-101May 28, 2018